Dr. Kevin Elinam Sikah is a Boston, Massachusetts based neurologist who is specialized in Neurology. Active license number of Dr. Kevin Elinam Sikah is 1022970 for Neurology in Massachusetts. His current practice location is 330 Brookline Ave, Boston. Patients can reach him at 617-667-4074 or can fax him at 617-667-2808. Dr. Kevin Elinam Sikah is MD in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1992321350. Dr. Kevin Elinam Sikah specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Kevin Elinam Sikah speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1992321350
NPI Enumeration Date:
22 Jun, 2020
NPI Last Update On:
09 Sep, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Kevin Elinam Sikah are as mentioned below.
License Number
Specialization
State
Status
1022970
Neurology
Massachusetts
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Kevin Elinam Sikah 330 Brookline Ave, Boston, Massachusetts
Zip:
02215-5400
Phone Number:
617-667-4074
Fax Number:
617-667-2808
Patients can reach Dr. Kevin Elinam Sikah at 330 Brookline Ave, Boston, Massachusetts or can call to book an appointment on 617-667-4074.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.